Skip to main content

Table 2 Antimicrobial resistance pattern for ESBL and Non- ESBL bacteria isolates, (% of resistance isolates within each group)

From: Detection of CTX-M-15 beta-lactamases in Enterobacteriaceae causing hospital- and community-acquired urinary tract infections as early as 2004, in Dar es Salaam, Tanzania

Antibiotic E. coli K. pneumoniae E. cloacae C. freundii P. mirabilis M. morganii P. rettgeri
  ESBL(+)
(n = 15)
ESBL (−)
(n = 95)
ESBL (+)
(n = 9)
ESBL (−)
(n = 18)
ESBL (+)
(n = 6)
ESBL (−)
(n = 5)
ESBL (+)
(n = 4)
ESBL (−)
(n = 5)
ESBL (+)
(n = 5)
ESBL (−)
(n = 2)
ESBL (+)
(n = 2)
ESBL (−)
(n = 5)
ESBL (−)
(n = 1)
AMC NA 14.7 NA 44.4 NA 80 NA 50 NA 0 NA 20 100
CTX NA 0.0 NA 0 NA 0 NA 0 NA 0 NA 0 0
CTZ NA 0.0 NA 0 NA 0 NA 0 NA 0 NA 0 0
CRO NA 1.1 NA 0 NA 0 NA 0 NA 0 NA 0 0
IMP 0 0 0 0 0 0 0 0 0 0 0 0 0
CHL 26.7 37.9 88.9 50 83.3 20 75 0 100 0 100 60 100
CIP 86.7 27.4 66.7 22.2 83.3 0 50 0 100 0 100 60 0
DO 100 73.7 66.7 44.4 83.3 60 100 40 100 100 100 80 100
CN 80 18 88.9 22.2 50 0 75 0 100 0 100 20 0
NAL 86.7 37.9 66.7 27.8 75 20 100 0 100 0 100 80 100
NIT 33.3 10.5 77.8 33.3 83.3 60 75 20 100 100 100 100 100
SXT 93.3 72.6 66.7 72.2 83.3 20 75 20 100 0 100 80 0
  1. AMC Amoxicillin-clavulanic acid, CTX cefotaxime, CTZ ceftazidime, CRO ceftriaxone, IMP imipenem, CHL chloramphenicol, CIP ciprofloxacin, DO doxycycline, CN gentamicin, NAL nalidixic acid, NIT nitrofurantoin, SXT trimethoprim-sulfamethoxazole
  2. NA Not applicable